Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. Horita N, Fujiwara Y. N Engl J Med 2024;390:287.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Horita N, Fujiwara Y. Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. N Engl J Med 2024;390:287.
PMID: 38231634